Loading...
Peptide CDMO Overcapacity And Debt Will Undermine Performance
n/a
n/a
AnalystLowTarget's Fair Value
n/a
1Y
-2.7%7D
2.3%1Y
-2.7%7D
2.3%You can edit this narrative until Aug 24 10:31 PM. Then, changes will post as Updates.
You can edit this narrative until Aug 24 10:31 PM. Then, changes will post as Updates.